December 2004
Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  
Nov   Jan


For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.


C H A N N E L S
• PULSE Home Page
• EXECUTIVE EDITION

• US News
• Canada News
• UK News
• New Zealand News

• Consumer Advocacy
• Health Care Systems
• Managed Care/Medicaid
• Co-occurring Disorders
• Clinical studies
• Pharmaceutical News
• Criminal Justice Systems
• Legislative News


U S E R ' S   G U I D E
About PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE


E M A I L   S U B S C R I P T I O N S

For WEEKLY summaries of PULSE postings, see the weekly email subscription form.

For DAILY mailings (powered by Bloglet), please enter your e-mail address below:


P U B L I C A T I O N S

PULSE ANNUAL No. 2
January 2003

Recent Trends, Challenges and Issues in Funding Public Mental Health Services in the US
March 2002

PULSE ANNUAL No. 1
October 2001

 

PULSE is powered by
Radio Userland.

Listed on BlogShares

© Bill Davis, 2000-2003.

About PULSE | Channels | User's Guide | Email subscriptions | Publications




PULSE is a free service of the Centre for Community Change International, gathering new and noteworthy Internet resources for mental health providers, family members of individuals with mental illness, consumers of mental health services and consumer advocates. PULSE is researched, edited and designed by Bill Davis.



daily link  Wednesday, December 08, 2004


UK Tightens Antidepressant Rules, Curbs Wyeth Drug
Reuters Health story at Medscape - "British health authorities tightened warnings on selective serotonin re-uptake inhibitor antidepressants, or SSRIs, on Monday, urging doctors to use them sparingly and consider non-drug interventions, such as counseling. The Medicines and Healthcare Products Regulatory Agency, which reviewed the drugs after concerns over their safety, said there should be stronger warnings about the risk of withdrawal reactions after ending a course of treatment. Doctors should also, in most cases, prescribe only the lowest recommended dose of SSRIs, and young adults should be monitored closely as a precautionary measure when being treated, it added. No antidepressant is recommended for the initial treatment of mild depression." [Viewing Medscape resources requires registration, which is free].  
permalink